As the name suggests, any content relevant to the research and study within the Pharma sector.
In their quest to meet patient need and demand for chronic pain relief, American doctors are often forced by consumer demands and practice challenges to prescribe and over prescribe narcotic painkillers. Their training and experience have not focused on alternative treatment options, until now. Drug-Dangers in Dosages According to a National Safety Council (NSC) 2016 […]
Continue reading THE ORDEAL OF OPIOIDS: Finding Alternative and Safer Substitutes
The successful implementation of “lean manufacturing” in various fields has inspired many businesses to adopt this model in their laboratories as well. However, laboratories have different challenges compared to manufacturing environments. In order to provide a way to gain the many benefits of lean operations in the lab, METTLER TOLEDO has developed the Lean Lab […]
Continue reading Lean Lab Checklist: More Efficient and Less Exhausting
Indian In-vitro Diagnostic Company, Transasia Bio-Medicals Ltd. recently launched Elan 30s as an addition to its products catering to the domain Immunoassays. Transasia offers products for multiple testing to suit the varying customer needs from a start –up laboratory to an advanced diagnostic centre. ELISA, which is used ubiquitously worldwide, is a trusted diagnostic tool. Over […]
Continue reading Elan 30s – A Comprehensive Solution for Blood Bank Serology
Genetic engineers and researchers alike have explicitly shared their affinity towards the gene-editing tool called CRISPR–Cas9. This device alters targeted genes effortlessly, thereby permitting an executable approach to developing treatments and cures. There is, however, a major limitation to Cas9 in terms of rectifying an isolated DNA letter in a gene. To address and remedy […]
Continue reading Singular Scissoring in Genetics – Dr. Liu & Team Have Now Made It Possible!
Ailments have certain corollaries that can’t be avoided. Loss of hunger or appetite is one among them. Not only is this consequential to multiple diseases and illnesses, it is also one of the most pernicious as it can incapacitate a patient to exponential levels of feebleness, sometimes even causing fatality (specific of cancer patients). TSRI […]
Up until now, photodynamic therapies have heavily relied on the content of O2 prevalent within the tissue. This, however, is rendered useless in the case of malignant and burgeoning tumours. Thus, a research team from Karlsruher Institut Fur Technologie (KIT) situated in Keiv, has contrived a photoswitchable molecule in order to supplement the method of […]
Continue reading “Photoswitchable Anti-Tumour Agents” May Mitigate Chemotherapy Side-Effects
The historical approach to clinical drug development, and one that served drug companies well for the past thirty years, was to initiate testing in humans at clinical research units, typically located in the UK and the US and to proceed further to Phase II testing and beyond to patients with clinical evidence of the disease […]
Over the past decade there has been increasing pressure on the pharmaceutical industry to increase economic efficiencies in drug discovery. This has been driven by several factors including the increased costs of R&D, lower productivity, patent expiration, generic competition and the increasing difficulty in bringing new chemical entities to market. The extraordinary investment requirements have […]
If you had run into Mark Engel, CEO and founder of Excel PharmaStudies, at the recent 2008 China Pharmaceutical R&D Summit at Shanghai, you would realise that even the young biotech industry in Asia is not immune to the rapid globalisation of drug discovery and development. Excel, a leading CRO, was started by a western […]
China has emerged from the shadows of isolation to become a world economic power with a staggering growth rate (8% per annum for the past five years) that will soon eclipse the likes of France and England. Low-cost manufacturing and the availability of inexpensive and abundant labour have fuelled this growth. However, in order to […]
Continue reading Outsourcing preclinical and clinical R&D to China
